Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
5
self-reported 2–10 band
Founded
2023
3 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Grant · Sep 2024 · US$ 300.0K
Company type
Privately Held
self-reported
Description
Synthesis Capital targets investments in technologies and ventures that can change the face of global healthcare.
Based in Australia and with a powerful pipeline across the Asia-Pacific region, Synthesis Capital invests in early-stage, deep technology medical, health and wellbeing-related ventures, from pre-seed to series A+.
Structured as an Australian Early Stage Venture Capital Limited Partnership (ESVCLP) with a stapled managed investment trust, Synthesis Capital Fund I is built to optimise tax benefits for limited partners while maintaining investment flexibility.
Synthesis Capital combines early-stage capital with market-leading venture development services – scaling its investment as risk is actively managed and addressed. Through powerful partnership with the MedTech Actuator – one of the Asia-Pacific’s leading medtech, healthtech and biotech venture development organisations – and its linkages across Singapore, India, South Korea and Japan, Synthesis Capital has direct access to a pipeline of investment-ready, high growth-potential enterprises, as well as the means to catalyse their development.
Specialties
All 5 specialties
- Venture Capital Fund
- Deep Technology
- Medical Technology
- Health Technology
- Impact
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUMelbournePrimary
Grid intelligence Members
Funding
Rounds1
Round typeGrant · non-equity funding
Amount (USD)300,000
Stage rank1
Investors named1
Since last round1 yr 4 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2023 to 2026 |
| Grant · 9 Sep 2024 | US$ 300.0K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at Synthesis Capital?
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Synthesis Capital have offices?
One address on record, Australia only. Primary: Melbourne.
Has Synthesis Capital raised funding?
One round. Latest 9 September 2024: grant, US$300,000, investor LaunchVic.
What does Synthesis Capital list as its specialties?
Five tags on the brand's own list, among them medical technology, impact and health technology.
Which companies are listed alongside Synthesis Capital?
7 profiles list Synthesis Capital as a peer — 70th percentile in Venture Capital and Private Equity Principals. It lists ten peers of its own. Dialectica Group and MedTech Actuator list it back.